291 – 300 of 470
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients.
(
- Contribution to journal › Article
-
Mark
Treatment Patterns and Outcomes in Patients Undergoing Percutaneous Coronary Intervention Treated With Prasugrel or Clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])
(
- Contribution to journal › Article
-
Mark
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: A retrospective analysis of the FEATHER study.
(
- Contribution to journal › Article
-
Mark
The enteric nervous system of P2Y13 receptor null mice is resistant against high-fat-diet- and palmitic-acid-induced neuronal loss.
(
- Contribution to journal › Article
-
Mark
The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial.
(
- Contribution to journal › Article
-
Mark
High-sensitivity troponin T as a diagnostic tool for acute coronary syndrome in the real world: an observational study.
(
- Contribution to journal › Article
-
Mark
MicroRNAs in the failing heart - Novel therapeutic targets?
(
- Contribution to journal › Scientific review
-
Mark
Temperature management in neurological and neurosurgical intensive care units.
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Inhibition of MicroRNA-125a Promotes Human Endothelial Cell Proliferation and Viability through an Antiapoptotic Mechanism.
(
- Contribution to journal › Article
-
Mark
Rapid Endovascular Catheter Core Cooling combined with cold saline as an Adjunct to Percutaneous Coronary Intervention For the Treatment of Acute Myocardial Infarction (The CHILL-MI trial).
(
- Contribution to journal › Article